UroGen Pharma Ltd. (FRA:UR8)

Germany · Delayed Price · Currency is EUR

18.20

-0.30 (-1.62%)

Last updated: Feb 20, 2026, 8:01 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology	90.40M	82.71M	64.36M	48.04M	11.80M
Biotechnology Growth	9.29%	28.52%	33.96%	307.17%	65450.00%
Total	90.40M	82.71M	64.36M	48.04M	11.80M
Total Growth	9.29%	28.52%	33.96%	307.17%	65450.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Israel	90.40M	82.71M	64.36M	48.04M	11.80M
Israel Growth	9.29%	28.52%	33.96%	307.17%	65450.00%
Total	90.40M	82.71M	64.36M	48.04M	11.80M
Total Growth	9.29%	28.52%	33.96%	307.17%	65450.00%

Source: S&P Global Market Intelligence.